Literature DB >> 31388825

The postoperative platelet distribution width is useful for predicting the prognosis in patients with esophageal squamous cell carcinoma.

Tomoyuki Matsunaga1, Hiroaki Saito2, Yoji Fukumoto1, Shota Shimizu1, Yusuke Kono1, Yuki Murakami1, Yuji Shishido1, Kozo Miyatani1, Manabu Yamamoto1, Naruo Tokuyasu1, Shuichi Takano1, Teruhisa Sakamoto1, Soichiro Honjo1, Yoshiyuki Fujiwara1.   

Abstract

PURPOSE: The platelet distribution width (PDW) is reportedly useful as a prognostic indicator for some cancers. However, its prognostic significance in esophageal squamous cell carcinoma (ESCC) is unclear.
METHODS: We enrolled 104 patients with thoracic ESCC, who underwent curative esophagectomy.
RESULTS: Receiver operating curve analyses indicated that the optimal cut-off values of pre- and postoperative PDW were 16.9 and 17.0, respectively. The 5-year overall survival (OS) rate was significantly lower in patients with a high-preoperative PDW (≥ 16.9; 52.6%) than in those with a low-preoperative PDW (< 16.9; 61.0% P = 0.045). The 5-year disease-specific survival (DSS) rates were 64.3% in patients with a high-preoperative PDW and 69.3% in those with a low-preoperative PDW (P = 0.13). Regarding the postoperative PDW, the 5-year OS rate was significantly lower in patients with a high-postoperative PDW (≥ 17.0; 35.7%) than in those with a low-postoperative PDW (< 17.0; 66.8% P = 0.0017). The 5-year DSS rates were 52.2% in patients with a high-postoperative PDW and 73.2% in those with a low-postoperative PDW (P = 0.037). Finally, a multivariate analysis revealed that the postoperative PDW but not the preoperative PDW was an independent prognostic factor.
CONCLUSIONS: The postoperative PDW was useful for predicting the prognosis of patients with ESCC.

Entities:  

Keywords:  Esophageal cancer; Platelet distribution width; Prognosis; Recurrence

Mesh:

Substances:

Year:  2019        PMID: 31388825     DOI: 10.1007/s00595-019-01860-3

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  39 in total

1.  VEGF, PF4 and PDGF are elevated in platelets of colorectal cancer patients.

Authors:  Jon E Peterson; David Zurakowski; Joseph E Italiano; Lea V Michel; Susan Connors; Marsha Oenick; Robert J D'Amato; Giannoula L Klement; Judah Folkman
Journal:  Angiogenesis       Date:  2012-03-09       Impact factor: 9.596

2.  Preoperative chemoradiotherapy for esophageal or junctional cancer.

Authors:  P van Hagen; M C C M Hulshof; J J B van Lanschot; E W Steyerberg; M I van Berge Henegouwen; B P L Wijnhoven; D J Richel; G A P Nieuwenhuijzen; G A P Hospers; J J Bonenkamp; M A Cuesta; R J B Blaisse; O R C Busch; F J W ten Kate; G-J Creemers; C J A Punt; J T M Plukker; H M W Verheul; E J Spillenaar Bilgen; H van Dekken; M J C van der Sangen; T Rozema; K Biermann; J C Beukema; A H M Piet; C M van Rij; J G Reinders; H W Tilanus; A van der Gaast
Journal:  N Engl J Med       Date:  2012-05-31       Impact factor: 91.245

3.  Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor.

Authors:  F Ishikawa; K Miyazono; U Hellman; H Drexler; C Wernstedt; K Hagiwara; K Usuki; F Takaku; W Risau; C H Heldin
Journal:  Nature       Date:  1989-04-13       Impact factor: 49.962

4.  Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma.

Authors:  Yong Guo; Zhaoli Chen; Liang Zhang; Fang Zhou; Susheng Shi; Xiaoli Feng; Baozhong Li; Xin Meng; Xi Ma; Mingyong Luo; Kang Shao; Ning Li; Bin Qiu; Keith Mitchelson; Jing Cheng; Jie He
Journal:  Cancer Res       Date:  2008-01-01       Impact factor: 12.701

5.  Clinical Importance of Supraclavicular Lymph Node Metastasis After Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma.

Authors:  Hiroshi Miyata; Makoto Yamasaki; Yasuhiro Miyazaki; Tsuyoshi Takahashi; Yukinori Kurokawa; Kiyokazu Nakajima; Shuji Takiguchi; Masaki Mori; Yuichiro Doki
Journal:  Ann Surg       Date:  2015-08       Impact factor: 12.969

6.  Interleukin-6 supports human megakaryocytic proliferation and differentiation in vitro.

Authors:  T Imai; K Koike; T Kubo; T Kikuchi; Y Amano; M Takagi; N Okumura; T Nakahata
Journal:  Blood       Date:  1991-10-15       Impact factor: 22.113

Review 7.  Hypercoagulation in colorectal cancer: what can platelet indices tell us?

Authors:  Charalampos Seretis; Haney Youssef; Mark Chapman
Journal:  Platelets       Date:  2014-09-05       Impact factor: 3.862

8.  Higher platelet distribution width predicts poor prognosis in laryngeal cancer.

Authors:  Huan Zhang; Li Liu; Shuang Fu; Yan-Song Liu; Changsong Wang; Tiemin Liu; Zhi-Ping Liu; Rui-Tao Wang; Kai-Jiang Yu
Journal:  Oncotarget       Date:  2017-07-18

9.  Inflammatory cytokines are associated with response and prognosis in patients with esophageal cancer.

Authors:  Susanne Blank; Henrik Nienhüser; Lena Dreikhausen; Leila Sisic; Ulrike Heger; Katja Ott; Thomas Schmidt
Journal:  Oncotarget       Date:  2017-07-18

10.  Combination of platelet count and mean platelet volume (COP-MPV) predicts postoperative prognosis in both resectable early and advanced stage esophageal squamous cell cancer patients.

Authors:  Fan Zhang; Zhaoli Chen; Pan Wang; Xueda Hu; Yibo Gao; Jie He
Journal:  Tumour Biol       Date:  2016-01-16
View more
  2 in total

1.  Mean platelet volume and platelet distribution width serve as prognostic biomarkers in skull base chordoma: a retrospective study.

Authors:  Mingxuan Li; Jiwei Bai; Shuai Wang; Yixuan Zhai; Shuheng Zhang; Chuzhong Li; Jiang Du; Yazhuo Zhang
Journal:  BMC Cancer       Date:  2020-10-12       Impact factor: 4.430

2.  Prognostic significance of the combination of preoperative red cell distribution width and platelet distribution width in patients with gastric cancer.

Authors:  Hiroaki Saito; Shota Shimizu; Yuji Shishido; Kozo Miyatani; Tomoyuki Matsunaga; Yoshiyuki Fujiwara
Journal:  BMC Cancer       Date:  2021-12-09       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.